Nu-Med Plus (NUMD) Property, Plant & Equipment (Net) Growth (1y) (2012 - 2022)
Nu-Med Plus (NUMD) Property, Plant & Equipment (Net) Growth (1y) (2012 - 2022) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.67 Bn | 194.07 Bn | 7.27 Bn | 12.44% |
| 2 | Stryker | 129.56 Bn | 126.09 Bn | 4.50 Bn | 6.92% |
| 3 | Medtronic | 119.87 Bn | 110.65 Bn | 6.41 Bn | 8.48% |
| 4 | Boston Scientific | 73.80 Bn | 73.27 Bn | 3.85 Bn | 19.21% |
| 5 | Edwards Lifesciences | 52.66 Bn | 48.41 Bn | 1.35 Bn | 6.67% |
| 6 | Dexcom | 34.56 Bn | 32.61 Bn | 830.00 Mn | 8.23% |
| 7 | GE HealthCare Technologies | 34.16 Bn | 32.05 Bn | 2.18 Bn | 6.21% |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | -1.40% |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 5.69% |
| 10 | Nu-Med Plus | 1.82 Mn | 1.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -99.55% |
| Mar 31, 2022 | -97.21% |
| Dec 31, 2021 | -80.52% |
| Sep 30, 2021 | -65.58% |
| Jun 30, 2021 | -56.34% |
| Mar 31, 2021 | -55.92% |
| Dec 31, 2020 | -50.35% |
| Sep 30, 2020 | -46.03% |
| Jun 30, 2020 | -41.45% |
| Mar 31, 2020 | -38.28% |
| Dec 31, 2019 | -36.33% |
| Sep 30, 2019 | -34.77% |
| Jun 30, 2019 | -32.96% |
| Mar 31, 2019 | -23.08% |
| Dec 31, 2018 | -20.89% |
| Sep 30, 2018 | -19.02% |
| Jun 30, 2018 | -17.76% |
| Mar 31, 2018 | 101.57% |
| Dec 31, 2017 | 101.49% |
| Sep 30, 2017 | 101.43% |